Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | IMA101 T cells |
Trade Name | |
Synonyms | ACTolog IMA101|IMA101 |
Drug Descriptions |
IMA101 T cells are autologous cytotoxic T lymphocytes that are expanded ex vivo and injected back into the patient with the potential to recognize specific tumor-associated antigens on cancer cells and subsequently, induce cell death (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C131305 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Aldesleukin + Cyclophosphamide + Fludarabine + IMA101 T cells | Aldesleukin Cyclophosphamide Fludarabine IMA101 T cells | 0 | 1 |
IMA101 T cells | IMA101 T cells | 0 | 0 |